Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Becton Dickinson and Company (BDX)

Healthcare Medical Instruments & Supplies

165.60 $

+0.1% vs. previous close

Closing price · As of: 31. Jul 2026

Becton Dickinson and Company (BDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 4,714 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Income Statement BDX
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	LTM
Revenue	4,878	5,087	4,706	5,045	4,990	5,437	5,168	5,272	5,509	5,890	5,252	4,714	21,365
Cost of Revenue	2,778	3,386	2,679	2,741	2,683	2,950	2,933	3,015	2,875	3,092	2,908	2,560	11,435
Gross Profit	2,100	1,701	2,027	2,304	2,307	2,487	2,235	2,257	2,634	2,798	2,344	2,154	9,930
Research & Development	306	281	290	299	299	302	343	302	297	322	318	249	1,186
Selling, General & Administrative	1,190	1,137	1,213	1,193	1,196	1,256	1,318	1,273	1,320	1,366	1,432	1,213	5,331
Total Operating Expenses	1,551	1,352	1,588	1,570	1,705	1,865	1,782	1,711	1,752	2,102	1,750	2,061	7,665
Operating Income	549	349	439	734	602	622	453	546	882	697	594	94	2,267
Interest Expense	119	113	111	125	137	155	155	151	152	155	107	149	563
Pre-Tax Income	471	181	359	633	500	514	306	363	703	510	487	39	1,739
Income Tax Expense	64	27	77	96	13	114	3.0	55	129	17	105	76	327
Net Income	407	108	281	537	487	400	303	308	574	493	382	-311	1,138
EBITDA	1,161	881	1,031	1,329	1,205	1,255	1,068	1,122	1,473	1,294	1,208	709	4,684

LTM = last twelve months (sum of the four most recent quarters).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings